Form 8-K Filing by Connect Biopharma Holdings Limited

Connect Biopharma Holdings Limited, incorporated in the Cayman Islands, filed a Form 8-K on December 17, 2025, reporting the immediate resignation of Dr. Kan Chen from its Board of Directors and the Nominating and Corporate Governance Committee. Dr. Chen, a partner at Qiming Venture Partners, cited the Company's strategic shift towards a U.S.-centric model, including a U.S.-based management team and R&D operations in the U.S. and Europe, as the reason for his departure, stating his contributions have positioned the Company for future growth. His resignation is not attributed to any disagreements regarding the Company's operations, policies, or practices. The filing also includes the cover page interactive data file as an exhibit.